How much does Smartway Pharmaceuticals Limited make?

Smartway Pharmaceuticals Limited reported revenue of £177m and £8m profit in the year to 31 Mar 2024, according to its accounts filed at Companies House.

How many employees does Smartway Pharmaceuticals Limited have?

Smartway Pharmaceuticals Limited reported an average of 103 employees in the year to 31 Mar 2024.

Is Smartway Pharmaceuticals Limited profitable?

Yes — Smartway Pharmaceuticals Limited reported a profit of £8m in the year to 31 Mar 2024.

Company No. 08481191 · Incorporated 9 Apr 2013

Smartway Pharmaceuticals Limited

Registered name: SMARTWAY PHARMACEUTICALS LIMITED

Part of Smartway PW. Holdings Limited group

Smartway Pharmaceuticals Limited made £177m revenue and £8m profit in the year to 31 Mar 2024.

Smartway Pharmaceuticals Limited’s revenue grew 21% to £177m in the year to 31 Mar 2024, with £8m profit and 103 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Leicester; we hold 3 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Leicester, East Midlands
Age: 13 yrs · since 2013
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2024

Key figures

Capital-light

Revenue

£177m

Growth ▲21%

Profit

£8m

Growth ▲5.4%

Profit margin

4.5%

Gross 11.7%

Employees

103

Change ▲6.2%

Profit / employee

£77.9k

Revenue/employee £1.7m

Profitable streak

3yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£135m	£146m	£177m
Cost of sales	£126m	£131m	£156m
Gross profit	£8.4m	£15m	£20.8m
Operating profit	£1.5m	£9.4m	£9.8m
Profit before tax	£1.6m	£9.4m	£9.9m
Profit after tax	£1.3m	£7.6m	£8m
Profit (best available)	£1.3m	£7.6m	£8m
Staff costs	£2.9m	£3.4m	£4.2m
Employees (average)	81	97	103
Ratios
Profit margin	0.9%	5.2%	4.5%
Gross margin	6.2%	10.3%	11.7%
Revenue per employee	£1.7m	£1.5m	£1.7m
Profit per employee	£15.6k	£78.5k	£77.9k
Growth (year on year)
Revenue growth	—	▲8.5%	▲21%
Profit growth	—	▲501.8%	▲5.4%
Headcount growth	—	▲19.8%	▲6.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£8.3m	£3.8m	£2.4m
Net assets	£39.9m	£17.5m	£12m
Fixed assets	£574k	£862k	£931k
Current assets	£45.5m	£63.7m	£61.7m
Debtors	£21.5m	£38.5m	£36.3m
Deferred income	£48.5k	£3.5m	£131k
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023	FullAccounts · bulk data Jan 2025

Derived from the latest filing

How the business works

Profit margin: 4.5%; Profit ÷ revenue.
Gross margin: 11.7%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1.7m; Revenue ÷ average employees.
Profit per employee: £77.9k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 0.5%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 0.1%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 20.5%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼32%; Now £12m
Cash at bank: ▼37%; Now £2.4m
Headcount: ▲6%; Now 103
Deferred income: ▼96%; Now £131k
Fixed assets: ▲8%; Now £931k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Smartway PW. Holdings Limitedultimate parent75–100%
Smartway Pharmaceuticals Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (8)

B2E Investment LimitedFigures not disclosed
Overture Capital LimitedFigures not disclosed
Pharmalink LimitedFigures not disclosed
Primis Capital LimitedFigures not disclosed
Smartway Investments LimitedFigures not disclosed
Smartway Pharma LimitedFigures not disclosed
Smartway Property LimitedFigures not disclosed
Smartway Wholesale LtdFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2024 (profit £8m), from the Companies House accounts bulk data published Jan 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.